HUM Humana Inc. Common Stock

NYSE · Health Care · 在 SEC EDGAR 上查看 ↗
$382.25
价格 · 八月 19, 2026
截至...的财报数据 七月 29, 2026

关于 Humana Inc. Common Stock 公司概况(来自维基百科)

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

阅读更多

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.

In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.

On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.

In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.

In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."

In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.

In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.

In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.

In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.

Corporate affairs

Sponsorship

Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.

Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.

Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.

The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.

In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.

On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

HUM 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$382.25
市值
$75.96B
P/E (TTM)
38.8
每股收益 (TTM)
$9.84
营收 (TTM)
$129.66B
股息收益率
0.56%
ROE
7.0%
负债/权益
0.7
52周区间
$163 – $429

HUM 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $129.66B
10-point trend, +138.4%
2016-12-31 2025-12-31
EPS $9.84
10-point trend, +141.8%
2016-12-31 2025-12-31
自由现金流 $375M
10-point trend, -73.4%
2016-12-31 2025-12-31
利润率 0.92%

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标
5年趋势
HUM
同行中位数
P/E (TTM)
5-point trend, +27.2%
38.8
36.8
P/S (TTM) (市销率 (TTM))
4-point trend, -64.2%
0.6
0.8
P/B (市净率)
4-point trend, -56.6%
4.3
3.4
EV / EBITDA (企业价值 / EBITDA)
4-point trend, -33.7%
25.3
Price / FCF (股价/自由现金流)
4-point trend, +362.5%
202.6

盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
HUM
同行中位数
Operating Margin (营业利润率)
5-point trend, -44.9%
2.1%
Net Profit Margin (净利润率)
5-point trend, -73.9%
0.92%
0.85%
ROA
5-point trend, -66.3%
2.5%
2.8%
ROE
5-point trend, -61.5%
7.0%
8.2%
ROIC
5-point trend, -26.6%
7.4%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
HUM
同行中位数
Debt / Equity (负债/股东权益比率)
5-point trend, +7.0%
0.7
Current Ratio (流动比率)
5-point trend, +23.3%
2.0
1.5
Quick Ratio (速动比率)
5-point trend, +18.1%
1.4

成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
HUM
同行中位数
Revenue YoY (营收同比增长)
5-point trend, +56.1%
10.1%
Revenue CAGR 3Y (营收3年复合年增长率)
5-point trend, +56.1%
11.8%
Revenue CAGR 5Y (营收5年复合年增长率)
5-point trend, +56.1%
10.9%
EPS YoY
5-point trend, -56.6%
-1.4%
Net Income YoY (净利润同比增长)
5-point trend, -59.5%
-1.6%

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
HUM
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, -56.6%
$9.84

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
HUM
同行中位数
Payout Ratio (派息率)
5-point trend, +199.9%
36.2%

股息 收益率、派息率、股息历史、5年CAGR

股息收益率
0.56%
派息率
36.2%
5年股息复合年增长率 (CAGR)
除息日金额
2026年6月26日$0.8850
2026年3月27日$0.8850
2025年12月26日$0.8850
2025年9月26日$0.8850
2025年6月27日$0.8850
2025年3月28日$0.8850
2024年12月31日$0.8850
2024年9月30日$0.8850
2024年6月28日$0.8850
2024年3月27日$0.8850
2023年12月28日$0.8850
2023年9月28日$0.8850
2023年6月29日$0.8850
2023年3月30日$0.8850
2022年12月29日$0.7880
2022年9月29日$0.7880
2022年6月29日$0.7880
2022年3月30日$0.7880
2021年12月30日$0.7000
2021年9月29日$0.7000

HUM 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 33 位分析师
  • 强烈买入 8 24.2%
  • 买入 8 24.2%
  • 持有 15 45.5%
  • 卖出 2 6.1%
  • 强烈卖出 0 0.0%

12个月价格目标

23 位分析师 · 2026-08-19
中位数目标 $415.00 +8.6%
平均目标 $416.43 +8.9%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

平均惊喜
0.42%
期间 EPS Actual EPS 预期 惊喜
2026年6月30日 $7.61 $7.29 0.32%
2026年3月31日 $10.31 $10.29 0.02%
2025年12月31日 $-3.96 $-4.05 0.09%
2025年9月30日 $3.24 $2.85 0.39%
2025年6月30日 $6.27 $5.98 0.29%
2025年3月31日 $11.58 $10.17 1.4%

同行比较(GICS 子行业) 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
HUM $50.90B 26.0 10.1% 0.92% 7.0%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
ELV $77.37B 13.9 12.5% 2.8% 13.3%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 13
HUM 的年度损益表数据
指标 趋势 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
SG&A Expense 12-point trend, +102.3% $15.45B $13.70B $13.19B $12.67B $10.12B $10.05B $7.38B $7.53B $6.57B $7.17B $7.29B $7.64B
Operating Income 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Interest Expense 10-point trend, +156.8% · · $493M $401M $326M $283M $242M $218M $242M $189M $186M $192M
Other Non-op 10-point trend, -451000000.00 $-451M $-181M $-137M $-68M $532M $-103M $506M $-33M $0 $0 · ·
Pretax Income 12-point trend, -33.7% $1.44B $1.62B $3.33B $3.57B $3.42B $4.67B $3.47B $2.07B $4.02B $1.55B $2.43B $2.17B
Income Tax 12-point trend, -75.6% $250M $413M $836M $762M $485M $1.31B $763M $391M $1.57B $938M $1.16B $1.02B
Net Income 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
EPS (Basic) 12-point trend, +32.7% $9.87 $10.01 $20.09 $22.20 $22.79 $25.47 $20.20 $12.24 $16.94 $4.11 $8.54 $7.44
EPS (Diluted) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Shares (Basic) 12-point trend, -21.9% 120,454,000 120,571,000 123,866,000 126,419,000 128,688,000 132,199,000 134,055,000 137,486,000 144,493,000 149,375,000 149,455,000 154,187,000
Shares (Diluted) 12-point trend, -22.5% 120,826,000 120,869,000 124,441,000 127,094,000 129,396,000 133,012,000 134,727,000 138,403,000 145,585,000 150,917,000 151,142,000 155,874,000
EBITDA 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
资产负债表 26
HUM 的年度资产负债表数据
指标 趋势 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +117.1% $4.20B $2.22B $4.69B $5.06B $3.39B $4.67B $4.05B $2.34B $4.04B $3.88B $2.57B $1.94B
Short-term Investments 7-point trend, +43.1% $15.70B $18.21B $16.63B $13.88B $13.19B $12.55B $10.97B · · · · ·
Receivables 12-point trend, +210.5% $3.27B $2.70B $2.04B $1.67B $1.81B $1.14B $1.06B $1.01B $854M $1.28B $1.16B $1.05B
Other Current Assets 12-point trend, +138.6% $9.56B $6.68B $6.63B $5.57B $6.49B $5.28B $3.81B $3.56B $2.95B $3.44B $4.71B $4.01B
Current Assets 12-point trend, +110.7% $32.73B $29.82B $29.99B $26.18B $24.89B $23.64B $19.89B $16.95B $17.40B $16.19B $15.71B $15.54B
PP&E (Net) 12-point trend, +81.7% $2.23B $2.53B $3.03B $3.22B $3.07B $2.37B $1.96B $1.74B $1.58B $1.50B $1.38B $1.23B
PP&E (Gross) 12-point trend, +89.9% $5.52B $5.67B $5.88B $6.36B $5.95B $5.49B $4.62B $4.05B $3.56B $3.19B $2.72B $2.91B
Accum. Depreciation 12-point trend, +95.8% $3.29B $3.14B $2.85B $3.14B $2.87B $3.12B $2.66B $2.31B $1.98B $1.69B $1.34B $1.68B
Goodwill 12-point trend, +199.8% $9.69B $9.63B $9.55B $9.14B $11.09B $4.45B $3.93B $3.90B $3.28B $3.27B $3.27B $3.23B
Intangibles 12-point trend, +156.4% $1.13B $1.44B $1.69B $1.76B $2.64B $329M $177M $245M $226M $280M $357M $440M
Other Non-current Assets 12-point trend, +97.6% $3.13B $3.38B $3.38B $3.38B $4.38B $2.13B $1.83B $1.38B $2.17B $2.23B $2.48B $1.58B
Total Assets 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Accounts Payable 12-point trend, +172.9% $5.72B $5.26B $6.57B $5.24B $4.51B $4.01B $3.75B $3.07B $4.07B $2.47B $2.21B $2.10B
Short-term Debt 5-point trend, +1694000000.00 · · · · · · · $1.69B $150M $300M $299M $0
Current Liabilities 12-point trend, +118.8% $16.35B $16.94B $18.87B $17.18B $15.33B $13.39B $10.93B $10.08B $9.41B $7.82B $8.15B $7.47B
Capital Leases 7-point trend, +25.9% $418M $392M $444M $456M $546M $355M $332M · · · · ·
Other Non-current Liabilities 12-point trend, +941.1% $2.46B $1.95B $1.66B $1.47B $2.38B $1.79B $1.14B $581M $237M $263M $235M $236M
Total Liabilities 12-point trend, +124.6% $31.17B $30.03B $30.75B $27.68B $28.25B $21.24B $17.04B $15.25B $17.34B $14.71B $14.33B $13.88B
Total Debt 12-point trend, +223.4% $12.37B $11.14B $10.21B $9.03B $10.54B $6.06B $4.97B $6.07B $4.92B $4.09B $4.12B $3.83B
Common Stock Flat — no change across 12 periods $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M
Retained Earnings 12-point trend, +193.2% $29.07B $28.32B $27.54B $25.49B $23.09B $20.52B $17.48B $15.07B $13.67B $11.45B $11.02B $9.92B
Treasury Stock 12-point trend, +404.8% $14.42B $14.37B $13.66B $12.16B $10.16B $9.92B $8.46B $7.32B $6.33B $3.30B $3.29B $2.86B
AOCI 12-point trend, -383.9% $-633M $-1.07B $-999M $-1.30B $42M $391M $156M $-159M $19M $-66M $58M $223M
Stockholders' Equity 12-point trend, +83.0% $17.66B $16.38B $16.26B $15.31B $16.08B $13.73B $12.04B $10.16B $9.84B $10.69B $10.35B $9.65B
Liabilities + Equity 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Shares Outstanding 7-point trend, +0.0% 198,719,000 198,719,000 198,690,000 198,667,000 198,649,000 198,649,000 198,630,000 · · · · ·
现金流 17
HUM 的年度现金流数据
指标 趋势 202520242023202220212020201920182017201620152014
D&A 10-point trend, +112.8% $698M $839M $779M $709M $596M · · $444M $410M $388M $354M $328M
Stock-based Comp 12-point trend, +145.9% $241M $207M $175M $216M $180M $181M $163M $137M $157M $115M $109M $98M
Deferred Tax 12-point trend, +217.2% $75M $-192M $-164M $-100M $15M $195M $162M $194M $132M $-71M $-2M $-64M
Amort. of Intangibles 12-point trend, -57.9% $51M $60M $67M $81M $65M $88M $70M $90M $75M $77M $93M $121M
Restructuring 2-point trend, -68.2% · · · · · · $47M · $148M · · ·
Operating Cash Flow 12-point trend, -43.1% $921M $2.97B $3.98B $4.59B $2.26B $5.64B $5.28B $2.17B $4.05B $1.94B $868M $1.62B
CapEx 12-point trend, +3.4% $546M $575M $1.00B $1.14B $1.34B $964M $736M $612M $524M $527M $523M $528M
Investing Cash Flow 12-point trend, +3707.9% $2.27B $-2.95B $-3.49B $-1.01B $-6.56B $-3.06B $-1.28B $-3.09B $-2.94B $-1.36B $320M $-63M
Net Debt Issued 6-point trend, +20.0% · · · · · · $-400M $0 $-800M $0 $0 $-500M
Stock Repurchased 12-point trend, -82.7% $151M $817M $1.57B $2.10B $79M $1.82B $1.07B $1.09B $3.37B $104M $385M $872M
Net Stock Activity 12-point trend, +82.7% $-151M $-817M $-1.57B $-2.10B $-79M $-1.82B $-1.07B $-1.09B $-3.37B $-104M $-385M $-872M
Dividends Paid 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M
Financing Cash Flow 12-point trend, -60.3% $-1.22B $-2.49B $-856M $-1.91B $3.02B $-1.96B $-2.29B $-785M $-945M $732M $-552M $-758M
Net Change in Cash 12-point trend, +148.3% $1.98B $-2.47B $-367M $1.67B $-1.28B $619M $1.71B $-1.70B $165M $1.31B $636M $797M
Taxes Paid 11-point trend, -44.7% · $570M $997M $758M $227M $1.13B $518M $631M $1.50B $916M $1.18B $1.03B
Free Cash Flow 12-point trend, -65.6% $375M $2.39B $2.98B $3.47B $946M $4.67B $4.55B $1.56B $3.52B $1.41B $345M $1.09B
Levered FCF 10-point trend, +163.8% · · $2.61B $3.15B $666M $4.47B $4.36B $1.38B $3.38B $1.33B $247M $989M
盈利能力 7
HUM 的年度盈利能力数据
指标 趋势 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
Net Margin 12-point trend, -61.0% 0.92% 1.0% 2.3% 3.0% 3.5% 4.4% 4.2% 3.0% 4.5% 1.1% 2.4% 2.4%
Pretax Margin 12-point trend, -75.2% 1.1% 1.5% 3.1% 3.8% 4.1% 6.1% 5.3% 3.6% 7.5% 2.9% 4.5% 4.5%
EBITDA Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
ROA 12-point trend, -52.0% 2.5% 2.6% 5.5% 6.4% 7.4% 10.5% 9.9% 6.4% 9.3% 2.5% 5.3% 5.2%
ROE 12-point trend, -42.3% 7.0% 7.4% 15.8% 18.2% 18.1% 22.8% 22.9% 16.2% 23.3% 5.8% 12.8% 12.1%
ROIC 12-point trend, -19.7% 7.4% 7.1% 11.3% 12.3% 10.1% 18.1% 14.6% 15.5% 17.6% 4.7% 8.5% 9.3%
流动性与偿付能力 5
HUM 的年度流动性与偿付能力数据
指标 趋势 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +0.1% 2.0 1.8 1.6 1.5 1.6 1.8 1.8 1.7 1.9 2.1 1.9 2.0
Quick Ratio 12-point trend, +236.0% 1.4 1.4 1.2 1.2 1.2 1.4 0.5 0.3 0.5 0.7 0.5 0.4
Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.6 0.5 0.4 0.4 0.4
LT Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.4 0.5 0.4 0.4 0.4
Interest Coverage 10-point trend, -33.8% · · 8.1 9.5 9.7 17.6 13.2 14.2 17.6 9.2 12.6 12.3
效率 2
HUM 的年度效率数据
指标 趋势 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +23.9% 2.7 2.5 2.4 2.1 2.1 2.4 2.4 2.2 2.0 2.2 2.3 2.2
Receivables Turnover 12-point trend, -5.2% 43.4 49.7 57.4 53.3 56.3 70.3 62.7 60.9 50.4 44.6 49.0 45.8
每股 7
HUM 的年度每股数据
指标 趋势 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +15.3% $88.85 $82.40 $81.85 $77.07 · · · · · · · ·
Revenue / Share 12-point trend, +244.9% $1073.15 $974.29 $854.81 $730.72 $641.94 $580.06 $481.63 $411.20 $369.32 $360.32 $359.19 $311.15
Cash Flow / Share 12-point trend, -26.6% $7.62 $24.54 $31.99 $36.09 $17.48 $42.39 $39.22 $15.70 $27.83 $12.83 $5.74 $10.38
Cash / Share 4-point trend, -17.0% $21.14 $11.18 $23.62 $25.47 · · · · · · · ·
Dividend / Share 3-point trend, +4.5% · · · · · · · · · $1 $1 $1
Dividend Paid / Share 12-point trend, +221.8% $4 $4 $3 $3 $3 $2 $2 $2 $1 $1 $1 $1
EPS (TTM) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
增长率 10
HUM 的年度增长率数据
指标 趋势 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +32.0% 10.1% 10.7% 14.5% 11.8% 7.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +4.2% 11.8% 12.3% 11.3% · · · · · · · · ·
Revenue CAGR 5Y 10.9% · · · · · · · · · · ·
EPS YoY 5-point trend, +86.6% -1.4% -50.1% -9.4% -2.6% -10.4% · · · · · · ·
EPS CAGR 3Y 3-point trend, -212.8% -23.6% -23.9% -7.5% · · · · · · · · ·
EPS CAGR 5Y -17.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +87.8% -1.6% -51.5% -11.3% -4.3% -12.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -160.0% -24.9% -25.6% -9.6% · · · · · · · · ·
Net Income CAGR 5Y -18.8% · · · · · · · · · · ·
Dividend CAGR 5Y 5.9% · · · · · · · · · · ·
估值 (TTM) 17
HUM 的年度估值 (TTM)数据
指标 趋势 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
Net Income TTM 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
Market Cap 4-point trend, -50.0% $50.90B $50.42B $90.96B $101.76B · · · · · · · ·
Enterprise Value 4-point trend, -52.8% $43.36B $41.13B $79.86B $91.85B · · · · · · · ·
P/E 12-point trend, +33.4% 26.0 25.4 22.9 23.2 20.5 16.2 18.2 23.6 14.8 50.1 21.2 19.5
P/S 4-point trend, -64.2% 0.4 0.4 0.9 1.1 · · · · · · · ·
P/B 4-point trend, -56.6% 2.9 3.1 5.6 6.6 · · · · · · · ·
P / Tangible Book 4-point trend, -67.8% 7.4 9.5 18.1 23.1 · · · · · · · ·
P / Cash Flow 4-point trend, +149.1% 55.3 17.0 22.8 22.2 · · · · · · · ·
P / FCF 4-point trend, +362.5% 135.7 21.1 30.6 29.3 · · · · · · · ·
EV / EBITDA 4-point trend, -33.7% 16.0 16.1 19.9 24.2 · · · · · · · ·
EV / FCF 4-point trend, +336.5% 115.6 17.2 26.8 26.5 · · · · · · · ·
EV / Revenue 4-point trend, -66.2% 0.3 0.3 0.8 1.0 · · · · · · · ·
Dividend Yield 4-point trend, +115.4% 0.84% 0.85% 0.47% 0.39% · · · · · · · ·
Earnings Yield 12-point trend, -25.0% 3.8% 3.9% 4.4% 4.3% 4.9% 6.2% 5.5% 4.2% 6.8% 2.0% 4.7% 5.1%
Payout Ratio 12-point trend, +141.3% 36.2% 35.7% 17.3% 14.0% 12.1% 9.6% 10.8% 15.8% 9.0% 28.8% 13.5% 15.0%
Annual Payout 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $129.66B$117.76B$106.37B$92.87B$83.06B
营业利润率 % 2.1%2.2%3.8%4.1%3.8%
净收入 $1.19B$1.21B$2.49B$2.81B$2.93B
稀释后每股收益 (EPS) $9.84$9.98$20.00$22.08$22.67
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
负债/股东权益比率 0.70.70.60.60.7
流动比率 2.01.81.61.51.6
速动比率 1.41.41.21.21.2
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $375M$2.39B$2.98B$3.47B$946M

最新新闻 提及该公司的近期头条新闻

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存,并会跟随您浏览所有股票。

机构持有人 (13F) 1050 家申报者 · $33.7B 总计 · 截至 2026年6月30日

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
255 (+136 与上一季度对比) 83 (-77 与上一季度对比) 316 (+44 与上一季度对比) 274 (-45 与上一季度对比) +8.8M

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
Dodge & Cox $4345737744 10940380 12.89% 股份
VANGUARD CAPITAL MANAGEMENT LLC $3115642737 7843620 9.24% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $2311405702 5818956 6.86% 股份
STATE STREET CORP $2172441313 5457072 6.45% 股份
EAGLE CAPITAL MANAGEMENT LLC $1528010749 3846762 4.53% 股份
Sessa Capital IM, L.P. $1480732883 3727740 4.39% 股份
GEODE CAPITAL MANAGEMENT, LLC $1181074714 2976242 3.50% 股份
Capital International Investors $950462637 2392826 2.82% 股份
NAYA CAPITAL MANAGEMENT UK LTD $728407339 1833763 2.16% 股份
NORGES BANK $694505009 1748414 2.06% 股份
GOLDMAN SACHS GROUP INC $659096868 1659274 1.96% 股份
FMR LLC $615633048 1549854 1.83% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544502820 1370784 1.62% 股份
Capital Research Global Investors $443462035 1116990 1.32% 股份
Slate Path Capital LP $428969795 1079930 1.27% 股份
Capital World Investors $406119738 1022425 1.21% 股份
Newport Trust Company, LLC $384768345 968653 1.14% 股份
CITADEL ADVISORS LLC $363376856 914800 1.08% 买入期权
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348908912 878377 1.04% 股份
DIMENSIONAL FUND ADVISORS LP $331490508 834526 0.98% 股份
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314921577 792814 0.93% 股份
CITADEL ADVISORS LLC $310904094 782700 0.92% 卖出期权
WELLINGTON MANAGEMENT GROUP LLP $282117958 710231 0.84% 股份
VANGUARD FIDUCIARY TRUST CO $267791027 674163 0.79% 股份
Maple Rock Capital Partners Inc. $249553862 628251 0.74% 股份
Diamond Hill Capital Management, LLC (Investment Advisor) $245555446 618185 0.73% 股份
GOLDMAN SACHS GROUP INC $232333978 584900 0.69% 买入期权
MARSHALL WACE, LLP $216873381 545978 0.64% 股份
CITADEL ADVISORS LLC $178080082 448316 0.53% 股份
High Ground Investment Management LLP $177941848 447968 0.53% 股份
1832 Asset Management L.P. $176401430 444090 0.52% 股份
BCV Asset Management Inc. $173695656 445719 0.52% 股份
BANK OF AMERICA CORP /DE/ $172703708 434781 0.51% 股份
Holocene Advisors, LP $165040541 415489 0.49% 股份
BNP PARIBAS FINANCIAL MARKETS $147490964 371308 0.44% 股份
MILLENNIUM MANAGEMENT LLC $140098700 352698 0.42% 股份
JANE STREET GROUP, LLC $137080622 345100 0.41% 买入期权
Swiss National Bank $134522525 338660 0.40% 股份
JANE STREET GROUP, LLC $122542370 308500 0.36% 卖出期权
STEADFAST CAPITAL MANAGEMENT LP $122423204 308200 0.36% 股份
BlackRock, Inc. $120890332 304341 0.36% 股份
Mitsubishi UFJ Asset Management Co., Ltd. $115565201 290935 0.34% 股份
VANGUARD ASSET MANAGEMENT, Ltd $109135401 274748 0.32% 股份
AMERIPRISE FINANCIAL INC $108302217 272614 0.32% 股份
Legal & General Group Plc $103424967 260372 0.31% 股份
Vanguard Global Advisers, LLC $103330825 260135 0.31% 股份
GOLDMAN SACHS GROUP INC $103078590 259500 0.31% 卖出期权
NEUBERGER BERMAN GROUP LLC $102585352 258258 0.30% 股份
BANK OF NOVA SCOTIA $102313941 257575 0.30% 股份
RHUMBLINE ADVISERS $102294748 257527 0.30% 股份
Sumitomo Mitsui Trust Group, Inc. $101464685 255437 0.30% 股份
GLENVIEW CAPITAL MANAGEMENT, LLC $100979680 254216 0.30% 股份
Gotham Asset Management, LLC $89318889 224860 0.27% 股份
Balyasny Asset Management L.P. $87965958 221454 0.26% 股份
FIRST TRUST ADVISORS LP $85094587 214226 0.25% 股份
Ensign Peak Advisors, Inc $83532585 210293 0.25% 股份
ADAGE CAPITAL PARTNERS GP, L.L.C. $83463866 210120 0.25% 股份
Brandywine Global Investment Management, LLC $80388706 313859 0.24% 股份
California Public Employees Retirement System $80274587 202091 0.24% 股份
WOLVERINE TRADING, LLC $76135109 298300 0.23% 买入期权
Camber Capital Management LP $73344000 300000 0.22% 股份
National Pension Service $70860473 178391 0.21% 股份
BARCLAYS PLC $70472788 177415 0.21% 股份
Susquehanna Portfolio Strategies, LLC $69949250 176097 0.21% 股份
Walleye Trading LLC $69473778 174900 0.21% 买入期权
CANADA PENSION PLAN INVESTMENT BOARD $68018761 171237 0.20% 股份
ARGA Investment Management, LP $66165730 166572 0.20% 股份
ORBIMED ADVISORS LLC $65183802 164100 0.19% 股份
Solel Partners LP $64742888 162990 0.19% 股份
AMF Tjanstepension AB $61961951 155989 0.18% 股份
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $60794124 153049 0.18% 股份
Perpetual Ltd $57945659 145878 0.17% 股份
CI INVESTMENTS INC. $57302560 144259 0.17% 股份
AMERICAN CENTURY COMPANIES INC $56575256 142426 0.17% 股份
Squarepoint Ops LLC $56047742 141100 0.17% 卖出期权
Aberdeen Group plc $53345852 134298 0.16% 股份
WOLVERINE TRADING, LLC $52653949 206300 0.16% 卖出期权
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $52178000 131358 0.15% 股份
ING GROEP NV $51583784 129862 0.15% 股份
Squarepoint Ops LLC $50685272 127600 0.15% 买入期权
Walleye Trading LLC $49573056 124800 0.15% 卖出期权
D. E. Shaw & Co., Inc. $46514462 117100 0.14% 买入期权
BRAIDWELL LP $45481690 114500 0.13% 股份
Jain Global LLC $43694200 110000 0.13% 卖出期权
BANK OF MONTREAL /CAN/ $43207208 108774 0.13% 股份
Zurcher Kantonalbank (Zurich Cantonalbank) $42190325 106214 0.13% 股份
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $42127167 106055 0.12% 股份
AVIVA PLC $41509093 104499 0.12% 股份
VIRGINIA RETIREMENT SYSTEMS ET Al $41468472 161904 0.12% 股份
ROYAL BANK OF CANADA $41033000 103301 0.12% 股份
Pentwater Capital Management LP $39722000 100000 0.12% 买入期权
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $39284661 98899 0.12% 股份
Point72 Asset Management, L.P. $39122595 98491 0.12% 股份
PFM Health Sciences, LP $37487638 94375 0.11% 股份
Summit Street Capital Management, LLC $36325372 91449 0.11% 股份
Columbus Hill Capital Management, L.P. $35501935 89376 0.11% 股份
Korea Investment CORP $34579193 87053 0.10% 股份
Quantinno Capital Management LP $32817091 82616 0.10% 股份
Fisher Funds Management LTD $32811563 82603 0.10% 股份
Swedbank AB $32034603 80647 0.10% 股份

公司内部人士 76 位内幕人士 · 46 位高管 · 27 位董事

内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
James A. Rechtin President & CEO 2025年5月14日 P 30474 0 0 $0
Bruce D Broussard Chief Executive Officer 2024年2月21日 A 110130 0 0 $0
Celeste Mellet Chief Financial Officer 2025年2月24日 A 29676 0 0 $0
Susan M Diamond Chief Financial Officer 2024年12月31日 J 20165 0 0 $0
Brian A Kane Chief Financial Officer 2021年2月22日 A 24342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer 2014年5月9日 G 14916 0 0 $0
George Renaudin II President, Insurance 2025年3月27日 J 15702 0 0 $0
David Dintenfass President, Enterprise Growth 2025年2月24日 A 16234 0 0 $0
Sanjay K Shetty President, CenterWell 2025年2月24日 A 11566 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions 2023年2月24日 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail 2022年12月15日 M 3983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery 2017年12月15日 M 222 0 0 $0
Thomas J Liston President - Retail Segment 2014年2月18日 A 105443 0 0 $0
James E Murray EVP & COO 2017年3月31日 J 34668 0 0 $0
Japan Mehta Chief Information Officer 2025年2月24日 A 8628 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. 2025年2月24日 A 1767 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer 2025年2月24日 A 11266 0 0 $0
Joseph C Ventura Chief Legal Officer 2025年2月24日 A 17267 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer 2025年2月24日 A 16717 0 0 $0
Timothy S. Huval Chief Administrative Officer 2024年12月31日 G 7111 0 0 $0
Samir Deshpande Chief Information Officer 2024年12月15日 M 14015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer 2024年2月21日 A 11723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. 2023年2月24日 F 3687 0 0 $0
William H Shrank Chief Medical Officer 2022年5月1日 M 4294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont 2022年3月22日 J 5723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. 2022年2月25日 F 6014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. 2021年3月16日 G 8168 0 0 $0
Elizabeth D Bierbower Strategic Advisor 2019年12月18日 M 18092 0 0 $0
Brian P. Leclaire Strategic Advisor 2019年12月15日 M 6339 0 0 $0
Jody L Bilney Chief Consumer Officer 2019年2月25日 A 9774 0 0 $0
Roy A Beveridge, Chief Medical Officer 2019年2月19日 M 10791 0 0 $0
Todoroff M Christopher Chief Legal Officer 2018年12月15日 M 11136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer 2018年12月15日 M 6476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer 2017年3月17日 M 4361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin 2014年2月18日 A 1101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services 2014年2月18日 A 15946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer 2013年6月24日 M 19347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off 2012年12月24日 G 2287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of 2012年4月28日 F 11946 0 0 $0
GOODMAN BRUCE J Sr. VP 2012年2月23日 A 23280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. 2009年2月4日 I 0 0 0 $0
Arthur P Hipwell Senior Vice President 2008年3月27日 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel 2008年2月25日 F 13836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer 2007年12月31日 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary 2007年2月23日 M 57548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm 2005年1月6日 M 0 0 0 $0
Kurt J Hilzinger 董事 2026年6月30日 A 19448 0 0 $0
Frank A Damelio 董事 2026年1月2日 A 20634 0 0 $0
Karen Katz 董事 2025年12月31日 A 590 0 0 $0
David T Feinberg 董事 2025年6月30日 A 441 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

激进投资者及 5%+ 股东 1 持仓

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
David A. Jones ×2 申报 2003年11月12日 初始申报 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF持仓 由 199 只交易所交易基金持有

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
FXH · First Trust Exchange-Traded Alpha... 2.95% 109132 NS 2026年4月30日 N-PORT
SMRI · EA Series Trust 2.54% 58016 NS 2026年4月30日 N-PORT
TGLB · T. Rowe Price Exchange-Traded Fun... 2.26% 2111 NS 2026年4月30日 N-PORT
SRHQ · Elevation Series Trust 1.63% 13322 NS 2026年4月30日 N-PORT
CVAR · ETF Opportunities Trust 1.51% 2473 NS 2026年4月30日 N-PORT
HWSM · HOTCHKIS & WILEY FUNDS /DE/ 1.23% 85 NS 2026年6月30日 N-PORT
EPMV · Harbor ETF Trust 1.20% 225 NS 2026年4月30日 N-PORT
ABCS · EA Series Trust 1.19% 441 NS 2026年5月29日 N-PORT
MFSV · MFS Active Exchange Traded Funds ... 1.14% 17702 NS 2026年5月31日 N-PORT
NUMV · Nushares ETF Trust 0.96% 17434 NS 2026年4月30日 N-PORT
FTA · First Trust Exchange-Traded Alpha... 0.95% 52223 NS 2026年4月30日 N-PORT
ITAN · EA Series Trust 0.77% 2259 NS 2026年5月29日 N-PORT
CGMM · Capital Group Equity ETF Trust I 0.72% 65925 NS 2026年5月31日 N-PORT
AUSF · Global X Funds 0.70% 19401 NS 2026年5月31日 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0.63% 211 NS 2026年5月31日 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0.59% 30459 NS 2026年4月30日 N-PORT
RXL · ProShares Trust 0.53% 1258 NS 2026年5月31日 N-PORT
FAB · First Trust Exchange-Traded Alpha... 0.47% 2755 NS 2026年4月30日 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.46% 55439 NS 2026年4月30日 N-PORT
FEX · First Trust Exchange-Traded Alpha... 0.45% 28340 NS 2026年4月30日 N-PORT
DEUS · DBX ETF Trust 0.43% 3849 NS 2026年5月29日 N-PORT
CURE · Direxion Shares ETF Trust 0.41% 2404 NS 2026年4月30日 N-PORT
SPXD · DBX ETF Trust 0.37% 81 NS 2026年5月31日 N-PORT
QARP · DBX ETF Trust 0.36% 887 NS 2026年5月29日 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0.34% 4484 NS 2026年5月31日 N-PORT
GMOV · GMO ETF Trust 0.34% 1004 NS 2026年5月31日 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0.32% 265500 NS 2026年5月31日 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0.29% 12439 NS 2026年5月31日 N-PORT
PALC · Pacer Funds Trust 0.29% 2779 NS 2026年4月30日 N-PORT
SPVU · Invesco Exchange-Traded Fund Trus... 0.28% 1250 NS 2026年5月31日 N-PORT
BRCE · MFS Active Exchange Traded Funds ... 0.27% 299 NS 2026年5月31日 N-PORT
FFLC · FIDELITY COVINGTON TRUST 0.26% 12272 NS 2026年4月30日 N-PORT
GSEW · Goldman Sachs ETF Trust 0.24% 14039 NS 2026年5月31日 N-PORT
AFLG · First Trust Exchange-Traded Fund ... 0.21% 4491 NS 2026年5月31日 N-PORT
FLCV · Federated Hermes ETF Trust 0.20% 634 NS 2026年5月31日 N-PORT
FLCC · Federated Hermes ETF Trust 0.18% 708 NS 2026年5月31日 N-PORT
ROUS · Lattice Strategies Trust 0.16% 3879 NS 2026年4月30日 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund ... 0.15% 4555 NS 2026年4月30日 N-PORT
HELO · J.P. Morgan Exchange-Traded Fund ... 0.15% 24794 NS 2026年4月30日 N-PORT
CATH · Global X Funds 0.13% 6791 NS 2026年4月30日 N-PORT
DFLV · Dimensional ETF Trust 0.13% 32836 NS 2026年4月30日 N-PORT
SCHG · SCHWAB STRATEGIC TRUST 0.13% 256808 NS 2026年5月31日 N-PORT
ACVF · ETF Opportunities Trust 0.13% 790 NS 2026年4月30日 N-PORT
OALC · Unified Series Trust 0.12% 945 NS 2026年5月31日 N-PORT
DFSU · Dimensional ETF Trust 0.12% 10240 NS 2026年4月30日 N-PORT
GSLC · Goldman Sachs ETF Trust 0.11% 55850 NS 2026年5月31日 N-PORT
GVUS · Goldman Sachs ETF Trust 0.11% 1461 NS 2026年5月31日 N-PORT
USSG · DBX ETF Trust 0.11% 2008 NS 2026年5月29日 N-PORT
VEGN · ETF Series Solutions 0.10% 675 NS 2026年4月30日 N-PORT
DFUV · Dimensional ETF Trust 0.09% 57804 NS 2026年4月30日 N-PORT